Answers are grounded in this paper and cite their sources.
Tumors launch malignant cells into the circulation continuously. In early stages, the immune surveillance system eliminates these cells from the circulation, but at later times they may persist longer and be detected. The first recorded evidence of the presence of circulating tumor cells in the peripheral blood of cancer patients was documented in 1869. Now, modern molecular biologic and cell sorting techniques make their detection and characterization more practicable. This review will consider the methods currently available for their detection and characterization, and the clinical implications of their presence in various malignant conditions.
No takes yet. Share an insight, caveat, or question.
Elshimali et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: